Key Takeaways

• Botox is fda approved for chronic migraine prevention since October 2010, using 155 units across 31 fixed dose injections every 12 weeks under the preempt protocol.
• The main botox injection sites span seven muscle groups: the frontalis muscle, corrugator and procerus complex, temporalis muscle, occipitalis, cervical paraspinal muscles, and trapezius muscles.
• Dosing follows a standardized injection pattern but can be customized with a “follow-the-pain” approach, bringing the total up to about 195 units across up to 39 sites.
• Migraine botox treatment differs from cosmetic botox in both total units administered and the locations targeted.
• Most patients see significant improvement after two treatment cycles, with injections repeated every 12 weeks to maintain relief.

Introduction: Botox for Chronic Migraine vs Cosmetic Botox

Botox for migraine is not the same procedure as the cosmetic treatment that smooths wrinkles on your forehead. While both use botulinum toxin type a (onabotulinumtoxinA), their goals, injection pattern, and doses diverge sharply. Botox was fda approved in October 2010 specifically for prevention of chronic migraine in adults. Chronic migraine is defined as having 15 or more headache days per month for at least three months, with at least eight of those days meeting migraine criteria.

Cosmetic botox typically uses 20–60 units across a handful of facial sites for wrinkle reduction. Migraine protocols follow the preempt clinical program, distributing 155–195 units across 31–39 migraines injection sites spanning the forehead, temples, back of the head, neck and shoulders.

Healthcare professionals seeking authentic products for migraine and aesthetic treatments can find Botox for sale at Ogomed alongside other trusted botulinum toxin options used in clinical practice.

Understanding the functional anatomy of muscles like the frontalis, temporalis, and cervical paraspinal group helps explain how botox works for migraine prevention and why it requires a different approach than a cosmetic treatment.

How Botox Works for Migraine Prevention

Botulinum toxin type a blocks acetylcholine release at the neuromuscular junction, causing muscle relaxation. But for migraine, the mechanism goes deeper. Botox works by reducing the release of pain mediators, including calcitonin gene related peptide (cgrp), substance p, and glutamate from peripheral nerve endings in the head and neck. This dampens peripheral sensitization, reducing nerve irritation that feeds pain signals to the brain.

Over repeated treatment cycles, this interruption of pain signaling pathways also helps prevent central sensitization, a process where the nervous system amplifies migraine pathophysiology and makes chronic headaches self-sustaining. Unlike cosmetic botox, the goal here is to block activation of pain pathways rather than simply smooth lines. Typical onset timeline: small changes in muscle contraction and tension may appear within 7–14 days, with clearer reduction in headache days by around week 4. Effects typically last about three months per treatment before wearing off.

Overview of the PREEMPT Injection Protocol (Sites and Total Units)

The preempt (Phase III REsearch Evaluating Migraine Prophylaxis Therapy) clinical trials established the standard fixed-site, fixed-dose injection pattern for chronic migraine. The fda approval regimen uses 155 units of onabotulinumtoxinA distributed across 31 injection sites every 12 weeks. Patients may receive botox injections up to four times a year on this schedule.

Clinicians may add up to 40 extra units across 8 additional “follow-the-pain” sites, bringing the total dose for botox to 155–195 units depending on where the patient reports the most severe symptoms. Each injection typically uses 5 units of botox. Injections are administered with a 30-gauge needle, placed intramuscular or just subdermal, in a brief office visit lasting about 5–10 minutes. Patients receive 31 to 39 injections during treatment.

Front of the Head: Glabella and Frontalis Muscle Injection Sites

Front-of-head injections target muscles that move the eyebrows and forehead, addressing face pain and migraine pain that concentrates in the frontal region.

The glabellar complex includes the procerus, located midline between the eyebrows, and the corrugator supercilii muscles, paired muscles running obliquely above the inner brows. The procerus receives 1 injection of 5 units. Each corrugator receives 1 injection of 5 units, placed about 1.5 cm above the medial superior orbital rim, totaling 10 units for the corrugator pair.

The frontalis muscle is a broad muscle across the forehead responsible for raise of the eyebrows and horizontal forehead lines. Under the preempt protocol, 4 sites receive 5 units each (20 units total), placed along the upper third of the forehead. Staying at least 2 cm above the brow line is important to avoid eyelid droop, a risk that increases when injections drift too low. While receiving botox here may also smooth wrinkles, migraine dosing prioritizes pain pathway interruption over cosmetic outcome, and the injection pattern is more standardized than typical cosmetic treatment approaches.

Sides of the Head: Temporalis Muscle Injection Sites and Units

Temporalis injections address migraine pain that radiates from the temples, one of the most common migraine locations. The temporalis muscle is a fan-shaped muscle on both sides of the skull involved in jaw closure. A healthcare provider can identify its bulk by asking the patient to clench their jaw, making the muscle easier to palpate before they inject botox.

The standard pattern places 4 injection sites per side, spaced across the anterior and middle temporal fossa, at 5 units per site. This totals 40 units for the temporalis region. Common injection sites include the occipitalis and temporalis muscles, making them central to the protocol. In patients who respond well but still report temporal symptoms, clinicians may add 1–2 follow-the-pain sites per side in this region.

Back of the Head: Occipitalis and Cervical Paraspinal Muscle Injection Sites

Many chronic migraine patients report pain at the skull base, corresponding to the occipitalis and cervical paraspinal muscles. The occipitalis is a thin muscle located near the external occipital protuberance on the back of the scalp. The cervical paraspinal group includes deeper neck extensors like splenius capitis and semispinalis capitis, muscles that support posture and frequently develop tension in chronic migraine.

Botox is injected into the cervical paraspinal muscles for migraine relief alongside the occipitalis. Standard dosing places 3 sites per side in the occipitalis (30 units) and 2 sites per side in the cervical paraspinal region (20 units). Practical landmarks: injections are placed 1–2 fingerbreadths below the occipital bone, lateral to the midline. Clinicians should avoid low cervical levels to reduce risk of neck weakness. Some patients also benefit from occipital nerve blocks as a complement, though these work through a different mechanism than botulinum toxin.

Neck and Shoulders: Trapezius and Additional Cervical Paraspinal Sites

The trapezius muscles and upper neck often hold significant tension in chronic migraine patients, contributing to pain referred upward to the head. The upper trapezius is a large, superficial muscle spanning from the skull and cervical spine to the shoulders and scapula, responsible for shoulder elevation and scapular stabilization.

Standard preempt trapezius dosing places 3 sites per side along the upper portion, from the neck base forward toward the acromion, at 5 units per site (30 units total). Injection sites include the forehead, temples, neck, and shoulders, with the trapezius often receiving extra follow-the-pain doses in patients with prominent neck and shoulders tension. Clinicians should avoid injecting too far lateral or too deep into the lower neck to prevent unwanted muscle weakness that could affect posture or function.

Fixed-Site, Fixed-Dose vs Follow-the-Pain: Customizing Botox Treatment

The “fixed-site, fixed-dose” concept means every patient receives the same 31-site, 155-unit injection pattern at every visit, regardless of day-to-day symptom variation. This approach has strong data from clinical trials, offers reproducible technique, and makes it easier to compare response over time.

The “follow-the-pain” add-on allows clinicians to place extra injections (5 units per site) into areas with persistent tenderness, such as additional temporalis or cervical paraspinal trigger point locations. Typical total dosing ranges from 155 to 195 units, depending on the patient’s migraine distribution. A physician experienced with migraine-specific functional anatomy should manage these additions, since inexperienced use of higher doses increases potential risks of side effects. As noted by researchers like quintana mariñez mg and brin mf, the evidence base for deviations from the standard protocol remains limited compared to the well-validated preempt model.

What a Typical Migraine Botox Session Looks Like

A typical procedure begins with check-in, a brief headache history update, and confirmation that at least 12 weeks have passed since the last session. The clinician marks key botox injection sites across the head, neck, and shoulders.

The actual injections take about 5–10 minutes. A 30-gauge needle delivers quick, shallow injections at each marked location. Patients typically report that the injections feel sore for a moment, with mild stinging or pressure. Botox typically covers 31–39 injection sites spanning the frontalis muscle, corrugator and procerus, temporalis, occipitalis, cervical paraspinal, and trapezius regions.

Post-procedure, most patients continue their day with minimal downtime. Aftercare guidance: avoid rubbing injection sites, vigorous exercise, and lying flat for several hours to limit unwanted toxin spread, especially near the eyes where it could affect eyelid function.

Safety, Side Effects, and Who Should Avoid Migraine Botox

Botox for migraine is generally well tolerated. In clinical trials, less than 4% of patients treated stopped botox due to side effects. However, awareness of potential risks helps set realistic expectations.

The most common side effects reported in trials include:

• Neck pain: 4.3% of patients treated
• Injection site pain: about 2.1%
• Eyelid droop: 1.9%
• Temporary flu-like muscle achiness
• Mild bruising at injection locations

Some patients may experience worsening migraine attacks initially after treatment, though this typically resolves quickly. Neck weakness can occur if injections are placed too deep in the cervical paraspinal region or trapezius.

Key contraindications: active skin infection at injection sites, history of neuromuscular junction disorders such as myasthenia gravis, and hypersensitivity to any ingredient. Women who are pregnant or breastfeeding should exercise caution due to limited long term management data. Botox shots should not be scheduled more frequently than every 12 weeks to reduce risk of developing neutralizing antibodies.

From a safety perspective, the benefits outweigh the potential risks for most chronic migraine patients when the procedure is administered by an experienced headache specialist.

Expected Results, Timeline, and When to Reassess

Botox effects typically last about three months per treatment. Many patients notice early changes in muscle tension within 1–2 weeks, but meaningful reduction in headache frequency takes longer. Clinical improvement is often seen after two treatment cycles (about 6 months).

Key efficacy data from the preempt trials:

• Botox reduces headache days by 7 to 10 per month on average
• About 50% of patients see a 50% reduction in headaches after two cycles
• Patients report up to a 50% reduction in headache days after two cycles of consistent treatment
• Botox can improve quality of life even without significant headache reduction, through decreased migraine symptoms severity and less reliance on other migraine medications

A headache diary or tracking app helps monitor headache days, medicine use, and functional impact. Most specialists recommend at least two to three rounds before judging whether botox for migraine is an effective treatment option. If chronic migraine improves to episodic migraine levels (fewer than 15 headache days per month) and remains stable, providers may consider spacing injections further apart.

Skipping scheduled botox treatments may cause symptom return, so maintaining consistent 12-week intervals is important for migraine management. Some chronic migraine patients also benefit from combining botox with other medications, including cgrp monoclonal antibodies, since their mechanisms of action differ, and such combinations are increasingly common in migraine treatment. Your physician or headache specialist can help determine whether the benefits of continued or combined migraine prophylaxis therapy justify the approach from both a health and education perspective.

FAQ

Is migraine Botox the same as cosmetic Botox in the forehead?

It is the same medication (onabotulinumtoxinA, a botulinum toxin type a product), but migraine botox follows a standardized medical dosing protocol across 31+ sites and 155+ units, while cosmetic botox uses far fewer units focused on wrinkle reduction. The injection pattern, total doses, and clinical goals are fundamentally different, even when some sites overlap. Migraine treatment based on the preempt protocol targets pain signals, not just appearance.

Can Botox for migraines make my forehead or eyebrows look “frozen”?

Frontal and glabellar injections can smooth lines and slightly reduce eyebrow movement as a secondary effect. However, migraine protocols place frontalis muscle injections high on the forehead and use balanced dosing to preserve natural expression. A tip for patients: discuss any cosmetic concerns with your healthcare provider before treatment so they can adjust placement while maintaining migraine efficacy.

What happens if I miss or delay a 12-week Botox treatment?

Migraine control may gradually wear off after 10–12 weeks as the botulinum toxin effect fades, leading to increased headache days and potentially more severe migraine attacks. One delayed cycle usually does not cause long-term problems, but consistent 12-week intervals are recommended for steady control. If you received your last treatment more than 14–16 weeks ago, your provider can resume the protocol without needing to restart from scratch.

How many treatment cycles should I try before deciding if Botox works for me?

Most headache specialists recommend at least two to three rounds (6–9 months) before judging response. Clinical trials show that patients who continue through multiple treatment cycles are more likely to achieve significant improvement in headache frequency. Respond to each cycle by tracking your headache days and sharing the data with your physician for an informed reassessment.

Can Botox for migraines be used together with CGRP antibodies or other preventives?

Many patients use botox alongside other preventive migraine medications such as cgrp monoclonal antibodies or oral preventives. Since their mechanisms differ, combining them helps some patients who do not fully respond to either treatment alone. This approach is increasingly used in developing migraine management strategies for refractory cases, and the combination sometimes allows later dose reductions of other medications under close medical supervision. Always discuss adding or changing medical conditions treatments with your healthcare provider to weigh potential risks against expected relief.

Related posts:

Visualization in the Pediatric Patient Nerve Monitoring Factors in a Standard Work Protocol for Adult Deformity Surgery Medical Complications Technique of Low-Grade Osteotomies for Semi-Rigid Deformities

Stay updated, free articles. Join our Telegram channel

Join